GRAIL, Inc. (GRAL)

60.42 +1.83 (+3.12%) USD  |  NASDAQ  |  Jun 11, 12:09
More

GRAIL EV to CFO

EV to CFO Chart

View EV to CFO for GRAL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical EV to CFO Data

View and export this data back to 2024. Start Trial.
Date Value
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Apogee Therapeutics, Inc. Upgrade
Evommune, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade

EV to CFO Related Metrics

EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade